A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations

April 01, 2019
https://clinicaltrials.gov/ct2/show/NCT03670953
Parkinson Disease
Principal Investigator: Peter A Le Witt, MD
Parkinson, Parkinson's, Parkinson's disease
Open
(248)661-6270